4//SEC Filing
Bowen Robert 4
Accession 0001179110-13-009366
CIK 0000815094other
Filed
May 29, 8:00 PM ET
Accepted
May 30, 5:29 PM ET
Size
17.1 KB
Accession
0001179110-13-009366
Insider Transaction Report
Form 4
ABIOMED INCABMD
Bowen Robert
Chief Financial Officer
Transactions
- Sale
Common Stock, $.01 par value
2013-05-28$22.18/sh−5,102$113,176→ 63,227 total - Award
Common Stock, $.01 par value
2013-05-28+9,000→ 72,227 total
Holdings
- 20,000
Stock Option (right to buy)
Exercise: $22.44From: 2013-05-22Exp: 2022-05-22→ Common Stock (20,000 underlying) - 100,000
Stock Option (Right to Buy)
Exercise: $15.92From: 2009-12-22Exp: 2018-12-22→ Common Stock (100,000 underlying) - 30,000
Stock Option (right to buy)
Exercise: $5.86From: 2010-03-31Exp: 2019-05-28→ Common Stock (30,000 underlying) - 42,285
Stock Option (right to buy)
Exercise: $5.86From: 2010-05-28Exp: 2019-05-28→ Common Stock (2,715 underlying) - 15,000
Stock Option (right to buy)
Exercise: $10.03From: 2011-06-03Exp: 2020-06-03→ Common Stock (15,000 underlying) - 20,000
Stock Option (Right to Buy)
Exercise: $23.15From: 2014-05-14Exp: 2024-05-14→ Common Stock (20,000 underlying)
Footnotes (4)
- [F1]Grant to reporting person of option to buy the number of shares of common stock set forth on Table II, Column 7, under the Abiomed, Inc. 2008 Stock Incentive Plan.
- [F2]These options become exerciseable in annual 25% increments, commencing on the date set forth in Table II, Column 6.
- [F3]Sale of common stock pursuant to reporting owner's 10b5-1 plan. Sold to pay tax obligations upon vesting.
- [F4]These restricted stock units will vest in 50% increments, the first 50% on May 22, 2014 and the remaining 50% on May 22, 2015.
Documents
Issuer
ABIOMED INC
CIK 0000815094
Entity typeother
Related Parties
1- filerCIK 0001347405
Filing Metadata
- Form type
- 4
- Filed
- May 29, 8:00 PM ET
- Accepted
- May 30, 5:29 PM ET
- Size
- 17.1 KB